Get the Stockscreener App
10.05
28.52%
2.23
After Hours:
16.34
6.29
+62.59%
Ventyx Biosciences Inc stock is traded at $10.05, with a volume of 6.51M.
It is up +28.52% in the last 24 hours and up +15.25% over the past month.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
See More
Previous Close:
$7.82
Open:
$7.9
24h Volume:
6.51M
Relative Volume:
1.63
Market Cap:
$717.15M
Revenue:
-
Net Income/Loss:
$-192.96M
P/E Ratio:
-3.0455
EPS:
-3.3
Net Cash Flow:
$-167.04M
1W Performance:
+14.86%
1M Performance:
+15.25%
6M Performance:
+383.17%
1Y Performance:
+315.29%
1-Day Range:
$7.08
$25.00
1-Week Range:
$7.08
$25.00
52-Week Range:
$0.783
$25.00
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Name
Ventyx Biosciences Inc
Sector
Industry
Phone
(760) 407-6511
Address
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Compare VTYX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
10.05 | 558.02M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Mar-12-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-12-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-07-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-07-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-07-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-07-23 | Downgrade | Stifel | Buy → Hold |
| Nov-07-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jun-14-23 | Resumed | Credit Suisse | Outperform |
| Mar-21-23 | Initiated | Wells Fargo | Overweight |
| Dec-19-22 | Initiated | Goldman | Buy |
| Nov-17-22 | Initiated | Morgan Stanley | Overweight |
| Sep-07-22 | Initiated | Stifel | Buy |
| Sep-01-22 | Initiated | H.C. Wainwright | Buy |
| May-09-22 | Initiated | Credit Suisse | Outperform |
| Mar-31-22 | Initiated | Canaccord Genuity | Buy |
| Feb-01-22 | Initiated | Oppenheimer | Outperform |
| Nov-15-21 | Initiated | Jefferies | Buy |
| Nov-15-21 | Initiated | Piper Sandler | Overweight |
View All
Ventyx Biosciences Inc Stock (VTYX) Latest News
Ventyx Biosciences Stock Pre-Market (+63%) : Unconfirmed LLY Takeover Rumors - Trefis
Ventyx (VTYX) Shares Soar 62.5% Overnight, Here's What's Going On With This Trending Stock - Benzinga
Ventyx (VTYX) Shares Soar 62.5% Overnight, Here's What's Going On With This Trending Stock - Benzinga
Sandisk, Alumis, Micron Technology, Ventyx Biosciences, And Western Digital: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Ventyx Biosciences Jumps 62% On Reported $1 Bln Acquisition Talks With Eli Lilly - Nasdaq
Report: Eli Lilly eyeing $1B-takeout of Ventyx - FirstWord
Ventyx Biosciences stock surges after Eli Lilly acquisition talks - Investing.com
Ventyx BiosciencVentyx Biosciences Stock Jumps 56% After Hours On Reports Of $1 Billion Eli Lilly Buyout - Stocktwits
Eli Lilly stock rises after hours on Nimbus obesity pill deal as Ventyx talks surface - ts2.tech
Ventyx Biosciences jumps on report Eli Lilly nears more than $1B deal - MSN
Lilly in talks to buy Ventyx Biosciences for more than $1 billion, WSJ reports - The Mighty 790 KFGO
Small Biotech Launches On Rumored $1 Billion Eli Lilly Buyout - Investor's Business Daily
After-hours movers: Strategy, Mobileye, Ventyx Bioscience, Praxis By Investing.com - Investing.com Nigeria
After-hours movers: Strategy, Mobileye, Ventyx Bioscience, Praxis - Investing.com
Eli Lilly Is Closing In on Deal With Biotech Ventyx, WSJ Says - Bloomberg.com
Lilly's Billion-Dollar Bet on Inflammation: Why the Ventyx Deal Is About 2030, Not Tomorrow - CTOL Digital Solutions
Eli Lilly (LLY) Nears Acquisition Deal with Ventyx Valued Over $1 Billion - GuruFocus
Eli Lilly said to be close to buying Ventyx for over $1B - breakingthenews.net
Ventyx Biosciences stock surges after Eli Lilly acquisition talks By Investing.com - Investing.com Nigeria
Lilly in talks to buy Ventyx Biosciences in more than $1 billion deal, WSJ reports By Reuters - Investing.com
Lilly in talks to buy Ventyx Biosciences in more than $1 billion deal, WSJ reports - marketscreener.com
Exclusive | Eli Lilly Nears Deal for Biotech Ventyx - The Wall Street Journal
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - GlobeNewswire Inc.
Ventyx Stock Jumps After Report of Eli Lilly Takeover Talks - The Wall Street Journal
Ventyx Biosciences (NASDAQ:VTYX) Shares Down 6.1%Time to Sell? - MarketBeat
Investors Purchase Large Volume of Call Options on Ventyx Biosciences (NASDAQ:VTYX) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Ventyx Biosciences, Inc. (VTYX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc.VTYX - PR Newswire
Ventyx Biosciences (NASDAQ:VTYX) Trading Up 2.8%Here's What Happened - MarketBeat
Ventyx Biosciences (NASDAQ:VTYX) Shares Down 3.4%Time to Sell? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ventyx Biosciences, Inc. (VTYX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Will Ventyx Biosciences Inc. stock benefit from green energy trendsBollinger Bands Signals & Affordable Market Insights - bollywoodhelpline.com
Bronstein, Gewirtz & Grossman, LLC Encourages Ventyx Biosciences, Inc. (VTYX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ventyx Biosciences, Inc. (VTYX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Ventyx Biosciences, Inc. (VTYX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ventyx Biosciences, Inc. (VTYX) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Ventyx Biosciences, Inc. (VTYX) And Encourages Stockholders to Reach Out - ACCESS Newswire
Will Ventyx Biosciences Inc. stock return to pre crisis levelsMarket Sentiment Summary & Free Fast Entry Momentum Trade Alerts - Улправда
Ventyx Biosciences, Inc.(NasdaqGS:VTYX) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ventyx Biosciences, Inc. (VTYX) And Encourages Stockholders to Connect - ACCESS Newswire
One Ventyx Biosciences Insider Raised Their Stake In The Previous Year - Yahoo Finance
Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives - Insider Monkey
VTYX DEADLINE NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Ventyx Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 30 Deadline in Securities Class Action – VTYX - Macau Business
Will Ventyx Biosciences Inc. stock split attract more investorsWeekly Risk Summary & Free Fast Gain Swing Trade Alerts - bolumsonucanavari.com
Is Ventyx Biosciences Inc. stock a safe haven assetJuly 2025 Spike Watch & Low Volatility Stock Suggestions - Улправда
Ventyx Biosciences (NASDAQ:VTYX) Insider John Nuss Sells 12,675 Shares - MarketBeat
Insider Selling: Ventyx Biosciences (NASDAQ:VTYX) CEO Sells 47,345 Shares of Stock - MarketBeat
Ventyx Biosciences Executives Conduct Share Transactions - TradingView — Track All Markets
Ventyx Biosciences (NASDAQ:VTYX) Trading 13.5% HigherStill a Buy? - MarketBeat
Ventyx Biosciences Inc Stock (VTYX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):